Bristol-Myers Squibb Appoints Paul Biondi Senior Vice President, Head of Business Development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Bristol-Myers Squibb Appoints Paul Biondi Senior Vice President, Head of Business Development
October 15, 2015 4:06 PM EDT
Leerink Partners reiterated an Outperform rating on Five Prime Therapeutics (NASDAQ: FPRX) following an announced exclusive $1.74Bn license and collaboration agreement with Bristol-Myers Squibb Company (NYSE: BMY) for the development and commercialization of FPRXs CSF1R antibody... More
October 15, 2015 2:20 PM EDT
Bristol-Myers Squibb (NYSE: BMY) announced that Paul Biondi has been appointed senior vice president, head of Business Development and will report to Charlie Bancroft, chief financial officer. In this role, Biondi will lead the development of strategic partnerships and pursue scientific innovations across commercial, development, discovery and technology platforms to complement the companys internal R&D pipeline. Biondi most recently served as senior vice president, head of R&D Operations, Bristol-Myers Squibb.
Paul has established himself as a dynamic and collaborative leader at Bristol-Myers Squibb and made... More
